A leading global medical device manufacturer specializing in products for blood transfusion, cardiovascular systems, and diabetes care. The company is widely recognized for its innovation in healthcare solutions and maintains a strong presence in both developed and emerging markets. Investors monitor its performance due to its consistent growth and strategic expansion in the medical technology sector.
2 members of Congress have disclosed 4 trades in Terumo Corporation (TRUMY), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 3 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-07-10 | Daniel Goldman | sell | $1K – $15K |
| 2023-03-31 | Daniel Goldman | buy | $1K – $15K |
| 2023-02-27 | Daniel Goldman | sell | $15K – $50K |
| 2017-08-17 | JAMES B. RENACCI | sell | $1K – $15K |